These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33525802)

  • 1. The non-T-cell-inflamed tumor microenvironment: contributing factors and therapeutic solutions.
    Horton BL; Spranger S
    Emerg Top Life Sci; 2017 Dec; 1(5):447-456. PubMed ID: 33525802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic β-catenin signaling suppresses CD8
    Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
    Biomed Pharmacother; 2019 Jul; 115():108921. PubMed ID: 31078045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
    Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF
    Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new paradigm for tumor immune escape: β-catenin-driven immune exclusion.
    Spranger S; Gajewski TF
    J Immunother Cancer; 2015; 3():43. PubMed ID: 26380088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-intrinsic oncogene pathways mediating immune avoidance.
    Spranger S; Gajewski TF
    Oncoimmunology; 2016 Mar; 5(3):e1086862. PubMed ID: 27141343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers.
    Kwee SA; Tiirikainen M
    Hepatoma Res; 2021; 7():. PubMed ID: 33553649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.
    Wang B; Tian T; Kalland KH; Ke X; Qu Y
    Trends Pharmacol Sci; 2018 Jul; 39(7):648-658. PubMed ID: 29678298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to Checkpoint Inhibition in Cancer Immunotherapy.
    Barrueto L; Caminero F; Cash L; Makris C; Lamichhane P; Deshmukh RR
    Transl Oncol; 2020 Mar; 13(3):100738. PubMed ID: 32114384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
    Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
    J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Gene Signatures of Tumor Microenvironment Yields Insight Into Mechanisms of Resistance to Immunotherapy.
    Wang B; Liu M; Ran Z; Li X; Li J; Ou Y
    Front Bioeng Biotechnol; 2020; 8():348. PubMed ID: 32528935
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy.
    Liu J; Yan J; Yan S; Wang Y; Zhang R; Hou P; He W; Ji M
    Nano Lett; 2019 Dec; 19(12):8708-8715. PubMed ID: 31744296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
    Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
    J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
    Yang L; Li A; Lei Q; Zhang Y
    J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy.
    Spranger S; Sivan A; Corrales L; Gajewski TF
    Adv Immunol; 2016; 130():75-93. PubMed ID: 26923000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment.
    Gajewski TF
    Semin Oncol; 2015 Aug; 42(4):663-71. PubMed ID: 26320069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt Signaling in Cancer Metabolism and Immunity.
    El-Sahli S; Xie Y; Wang L; Liu S
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.